RYBELSUS® TABLET 3mg
Product details
Registration number: SIN16215P
Classification: Prescription Only
Active ingredients: Semaglutide
Strength: 3mg
Dosage form: TABLET
Route: ORAL
Registrant: NOVO NORDISK PHARMA (SINGAPORE) PTE LTD
ATC code: A10BJ06
HSA approval date: 1 June 2021
Manufacturer(s):
- Novo Nordisk A/S
- Novo Nordisk A/S (Primary packager and Secondary packager)
Manufacturing country/countries: DENMARK
What are the HSA registration number and classification for RYBELSUS® TABLET 3mg?
According to the HSA dataset updated 7 August 2026:
Registration number: SIN16215P
Classification: Prescription Only
What active ingredients and strength are recorded for RYBELSUS® TABLET 3mg?
According to the HSA dataset updated 7 August 2026:
Active ingredients: Semaglutide
Strength: 3mg
Ingredients and strengths are listed separately as recorded by HSA; their positions do not establish a one-to-one match. This is not a dosing instruction.
What dosage form and route are recorded for RYBELSUS® TABLET 3mg?
According to the HSA dataset updated 7 August 2026:
Dosage form: TABLET
Route: ORAL
Who is the recorded registrant for RYBELSUS® TABLET 3mg?
According to the HSA dataset updated 7 August 2026:
Registrant: NOVO NORDISK PHARMA (SINGAPORE) PTE LTD
Which manufacturers and countries are listed for RYBELSUS® TABLET 3mg?
According to the HSA dataset updated 7 August 2026:
Manufacturer(s):
- Novo Nordisk A/S
- Novo Nordisk A/S (Primary packager and Secondary packager)
Manufacturing country/countries: DENMARK
Where can I look up RYBELSUS® TABLET 3mg in the HSA register?
Open HSA’s therapeutic product register and search for registration number SIN16215P or the exact product name RYBELSUS® TABLET 3mg. The general register link does not preselect this product.
What are the source dates for this RYBELSUS® TABLET 3mg record?
This record is from HSA’s List of Registered Therapeutic Products on data.gov.sg. Dataset update: 7 August 2026. Retrieval date: 13 November 2026.
The dataset date is a snapshot date, not a separate current-register check for every product. Later direct checks are recorded separately.
Has this RYBELSUS® TABLET 3mg record had a separate HSA register check?
No separate current-register check is recorded for this product. Its presence in the imported dataset does not establish its current registration status.
Search the HSA register using SIN16215P for the latest record.
Sources and dates
HSA dataset: 2026. Updated: 13 November 2026.
Factual product information only; no dosing, treatment or suitability advice.
Updated and reviewed by: Dr Joel Lim MBChB UK (PG Dip Dermatology), Resident Physician.
.png)